Development and validation of a nomogram to predict overall survival in patients with glioma: a population-based study
Aging · 2024
DOI: 10.18632/aging.205967 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Aging, 2024. Verfasst von Wei Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Shenzhen Longhua District Maternity and Child Healthcare Hospital, Shenzhen 518109, China. Hauptthemen laut MEDLINE: Nomograms, Glioma, Brain Neoplasms, SEER Program. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Shenzhen Longhua District Maternity and Child Healthcare Hospital, Shenzhen 518109, China.
- Department of Pharmacy, Shenzhen Hospital of Guangzhou University of Chinese Medicine, Shenzhen 518034, China.
- Department of Neurology, Shenzhen Longhua District Central Hospital, Shenzhen 518110, China.
- Department of Pharmacy, Shenzhen Longhua District Central Hospital, Shenzhen 518110, China.
Zitieren
APA
Huang, W., Lei, Y., Cao, X., Xu, G., & Wang, X. (2024). Development and validation of a nomogram to predict overall survival in patients with glioma: a population-based study. Aging. https://doi.org/10.18632/aging.205967
Vancouver
Huang W, Lei Y, Cao X, Xu G, Wang X. Development and validation of a nomogram to predict overall survival in patients with glioma: a population-based study. Aging. 2024. doi:10.18632/aging.205967
BibTeX
@article{Huang2024,
author = {Huang, Wei and Lei, Yuhe and Cao, Xiongbin and Xu, Gengrui and Wang, Xiaokang},
title = {Development and validation of a nomogram to predict overall survival in patients with glioma: a population-based study},
journal = {Aging},
year = {2024},
doi = {10.18632/aging.205967}
}
EUVIMED